ALBERT DAVID
|
ALBERT DAVID Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 63.38 | 61.78 | 38.80 | 33.59 | 46.68 |
| CEPS(Rs) | 78.36 | 77.21 | 53.22 | 47.03 | 58.97 |
| DPS(Rs) | 9.00 | 9.00 | 6.00 | 7.00 | 6.00 |
| Book NAV/Share(Rs) | 545.93 | 489.68 | 428.20 | 390.38 | 368.74 |
| Tax Rate(%) | 28.70 | 25.45 | 19.31 | 33.80 | 37.84 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.33 | 12.38 | 7.40 | 9.04 | 8.77 |
| EBIT Margin(%) | 14.23 | 14.51 | 10.84 | 8.87 | 13.12 |
| Pre Tax Margin(%) | 14.07 | 14.30 | 10.54 | 8.58 | 12.86 |
| PAT Margin (%) | 10.03 | 10.66 | 8.50 | 5.68 | 7.99 |
| Cash Profit Margin (%) | 12.40 | 13.33 | 11.66 | 7.95 | 10.10 |
| Performance Ratios | |||||
| ROA(%) | 7.33 | 8.01 | 5.51 | 4.95 | 7.23 |
| ROE(%) | 12.24 | 13.46 | 9.48 | 8.85 | 13.44 |
| ROCE(%) | 17.10 | 18.10 | 11.99 | 13.74 | 20.60 |
| Asset Turnover(x) | 0.73 | 0.75 | 0.65 | 0.87 | 0.90 |
| Sales/Fixed Asset(x) | 1.61 | 1.52 | 1.23 | 1.67 | 1.74 |
| Working Capital/Sales(x) | 1.76 | 2.26 | 1.83 | 2.81 | 2.84 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.62 | 0.66 | 0.81 | 0.60 | 0.58 |
| Receivable days | 28.00 | 24.56 | 34.76 | 28.06 | 26.88 |
| Inventory Days | 45.48 | 41.36 | 54.98 | 46.93 | 47.78 |
| Payable days | 131.04 | 115.22 | 164.75 | 166.80 | 149.36 |
| Valuation Parameters | |||||
| PER(x) | 8.08 | 8.61 | 9.71 | 9.58 | 8.44 |
| PCE(x) | 6.53 | 6.89 | 7.08 | 6.84 | 6.68 |
| Price/Book(x) | 0.94 | 1.09 | 0.88 | 0.82 | 1.07 |
| Yield(%) | 1.76 | 1.69 | 1.59 | 2.18 | 1.52 |
| EV/Net Sales(x) | 0.80 | 0.92 | 0.73 | 0.56 | 0.69 |
| EV/Core EBITDA(x) | 4.54 | 5.10 | 4.97 | 4.76 | 4.30 |
| EV/EBIT(x) | 5.29 | 6.03 | 6.42 | 5.98 | 4.99 |
| EV/CE(x) | 0.53 | 0.61 | 0.45 | 0.45 | 0.58 |
| M Cap / Sales | 0.86 | 0.97 | 0.87 | 0.57 | 0.71 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 8.95 | 26.70 | -22.86 | 1.13 | 9.25 |
| Core EBITDA Growth(%) | 5.45 | 55.72 | -3.07 | -25.87 | 100.45 |
| EBIT Growth(%) | 6.98 | 69.94 | -5.72 | -31.52 | 158.05 |
| PAT Growth(%) | 2.60 | 59.23 | 15.52 | -28.05 | 170.71 |
| EPS Growth(%) | 2.60 | 59.23 | 15.52 | -28.05 | 170.71 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.02 | 0.01 | 0.01 | - |
| Current Ratio(x) | 2.08 | 1.81 | 2.05 | 1.81 | 1.81 |
| Quick Ratio(x) | 1.81 | 1.59 | 1.79 | 1.52 | 1.50 |
| Interest Cover(x) | 87.91 | 71.35 | 36.00 | 30.41 | 50.78 |
| Total Debt/Mcap(x) | 0.02 | 0.02 | 0.01 | 0.01 | - |
Compare Financial Ratios of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹681.7 Cr | 0.3% | -21.1% | 106.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹356,001.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
| CIPLA | ₹108,813.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹100,075.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,325.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹96,553.2 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 0.3% |
-21.1% |
106.1% |
| SENSEX | 0.5% |
1.4% |
23.5% |
You may also like the below Video Courses
